Please provide your email address to receive an email when new articles are posted on . Fasinumab, a recombinant, fully-human anti-nerve-growth-factor antibody, improved pain and physical function in ...
ATLANTA -- A new study presented at ACR Convergence, the American College of Rheumatology's annual meeting, shows that after three months of treatment with oral methotrexate, adults with primary knee ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results